Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

How has the Sonic (ASX:SHL) share price reacted since the FY20 report?

The Sonic Healthcare Limited (ASX:SHL) share price has dropped since the release of the FY20 report. 

The Sonic Healthcare Limited (ASX: SHL) share price has dropped since the release of the FY20 report.

Source: Rask Media SHL 1-year share price chart.

FY20 result

Sonic reported a decent set of numbers in FY20.

The healthcare business said that underlying revenue rose by 11.5% to $6.8 billion and underlying net profit grew by 6.5% to $552 million. The underlying EBITDA (click here to learn what EBITDA means) generated was $1.11 billion, better than the $1.075 billion it said in a recent trading update.

Sonic said that it’s playing a key role in combating the COVID-19 pandemic in its markets whilst continuing to provide essential routine healthcare services.

The final dividend was maintained at $0.51 per share, meaning the total dividend was up 1.2% to $0.85 per share.

However, the market didn’t seem to love the report as the share price has fallen by 8% since its release.

What about FY21?

Sonic Healthcare said that its base business volumes had largely recovered by 30 June 2020. Since the end of FY20, the company said that revenue growth rates have been “substantially higher than usual, boding well for the 2021 year”. However, it is uncertain how long these growth rates will continue.

The Sonic share price has recovered strongly since the COVID-19 crash. Despite the recent decline it’s actually still higher than the pre-COVID-19 price.

For long term investors, Sonic has been among the best blue chip ASX growth shares. Low interest rates go some way to justify today’s valuation. However, it’s too expensive for me.

I like the global diversification offered by Sonic –  it generates earnings across Europe, North America and Australia. However, it’s hard to say what the long term earnings growth rate will be. It’s already a $15 billion business. I think bigger businesses are naturally going to have slower growth rates than smaller ones.

There are other ASX growth shares I would prefer to buy such as Pushpay Holdings Ltd (ASX: PPH) which benefits as a software provider. Consumer business Bubs Australia Ltd (ASX: BUB) is a high risk, potentially high reward business that could make big returns too.

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

At the time of publishing, the author of this article does not have a financial or commercial interest in any of the companies mentioned.
Skip to content